FDA To Hold Workshop On Developing Drugs For Female Sex Problems

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

In response to criticism that the FDA harbors a gender bias, agency officials have scheduled a two-day workshop in October to discuss female sexual dysfunction and ideas for developing appropriate drugs.

The move, which was announced this week on the FDA website, comes amid ongoing controversy over claims by some consumer advocacy groups and drug makers that the agency has failed to approve medications to combat female sexual problems. At the same time, they argue that nearly two dozen such treatments exist for men.

Help employers find you! Check out all the jobs and post your resume.

Back to news